Status:
COMPLETED
Evaluation of the Active Sentry System During Cataract Surgery With the Centurion Phacoemulsifier
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Cataract Surgery
Eligibility:
All Genders
18+ years
Brief Summary
Each new generation of phacoemulsification system has aimed to optimize the control of fluidics and the delivery of energy during phacoemulsification. Nicoli CM et al., (J Cataract Refract Surg 2016;4...
Eligibility Criteria
Inclusion
- All consecutive patients undergoing unilateral or bilateral cataract surgery with the Centurion phacoemulsifier, with the ability to give informed consent.
- Patients will undergo the cataract surgery with or without the Active Sentry module and with or without hybrid tip according to centers practice.
- Patients will undergo a cataract scoring (nuclear grade 1 to 3) prior surgery as described in the WHO recommendation:
Exclusion
- Patients with :
- pupil dilation \<5mm
- zonular defects
- corneal opacities
Key Trial Info
Start Date :
May 5 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 3 2022
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT04732351
Start Date
May 5 2021
End Date
March 3 2022
Last Update
July 8 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ophtalmopôle, Hôpital Cochin
Paris, Île-de-France Region, France, 75014